U.S. Markets close in 5 hrs 1 min


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.4500-0.0500 (-2.00%)
As of 10:16AM EDT. Market open.


27042 Towne Centre Drive
Suite 270
Foothill Ranch, CA 92610-2811
United States
949 361 1200

IndustryMedical Devices
Full Time Employees158

Key Executives

NameTitlePayExercisedYear Born
Mr. John R. BeaverPres, CEO & Director876.18kN/A1961
Ms. Jennifer BrightChief Financial OfficerN/AN/AN/A
Mr. Steven SandorChief Operating OfficerN/AN/AN/A
Mr. Matthew WilsonVP of HRN/AN/AN/A
Dr. Samuel B. LowChief Dental Officer and VP of Dental & Clinical AffairsN/AN/AN/A
Mr. Michael C. CarrollCorp. Sec.N/AN/A1972
Mr. David RodriguezDirector of Education & EventsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Corporate Governance

BIOLASE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.